The Impact on Future Prescribing Patterns of Opioid Use Disorder (OUD) Education and Waiver Provision During Residency

From the Department of Family Medicine, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill (VB, CGW, EBF, KBF); UNC Health Sciences at MAHEC, Asheville, NC (CGW, EBF, CRT); Division of Practice Advancement and Clinical Education, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill (CGW); Department of Family and Community Medicine, Wake Forest School of Medicine, Winston-Salem, NC (JK); Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC (CRT)

From the Department of Family Medicine, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill (VB, CGW, EBF, KBF); UNC Health Sciences at MAHEC, Asheville, NC (CGW, EBF, CRT); Division of Practice Advancement and Clinical Education, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill (CGW); Department of Family and Community Medicine, Wake Forest School of Medicine, Winston-Salem, NC (JK); Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC (CRT)

From the Department of Family Medicine, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill (VB, CGW, EBF, KBF); UNC Health Sciences at MAHEC, Asheville, NC (CGW, EBF, CRT); Division of Practice Advancement and Clinical Education, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill (CGW); Department of Family and Community Medicine, Wake Forest School of Medicine, Winston-Salem, NC (JK); Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC (CRT)

From the Department of Family Medicine, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill (VB, CGW, EBF, KBF); UNC Health Sciences at MAHEC, Asheville, NC (CGW, EBF, CRT); Division of Practice Advancement and Clinical Education, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill (CGW); Department of Family and Community Medicine, Wake Forest School of Medicine, Winston-Salem, NC (JK); Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC (CRT)

From the Department of Family Medicine, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill (VB, CGW, EBF, KBF); UNC Health Sciences at MAHEC, Asheville, NC (CGW, EBF, CRT); Division of Practice Advancement and Clinical Education, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill (CGW); Department of Family and Community Medicine, Wake Forest School of Medicine, Winston-Salem, NC (JK); Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC (CRT)

From the Department of Family Medicine, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill (VB, CGW, EBF, KBF); UNC Health Sciences at MAHEC, Asheville, NC (CGW, EBF, CRT); Division of Practice Advancement and Clinical Education, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill (CGW); Department of Family and Community Medicine, Wake Forest School of Medicine, Winston-Salem, NC (JK); Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC (CRT)